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  Combination intensive therapy of cis－diamminedichloroplatinum （CDDP）， bleomycin （BLM）
and vihcristine （VCR） was administered to 5 patients with stage IV renal adenocarcinoma， all of
whom had received nephrectomy． Following this 2－3－month intensive therapy， maintenance therapies
consisting of CDDP．BLM．VCR and CDDP．VCR were given．
  Two patients achieved objective responses （1 patient； complete remission）， and 1 patient achieved
a subjective response． One patient died of side effects． Renal dysfunction with elevation of serum
creatinine was seen in 2 patients， a leucocyte count of less than 1000／mm3 in 1 patient， and pulmonary
fibrosis in 2 patients．
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．Table 1．
Case Name Sex AgbOperatienStage  PreviousChemotherapyMeta＄tasis
1 S．T． Male 76
2 C．H． Male 71
3 M．K， Male 45
4 ・J．N， Male 68






























Table 2 ． New Anticancer ChemntherapY Regimen for Stage IV Renal
    cinoma ： CBV Regimen ：
Adenocar一
i ． lntensive oremotherapy
   CDDP 25mg
   B LM 10mg
   V C R ’2mg
  （P R D） （20mg）
2．’（1＞ Maintenance Therapy
   CDDP ・25mg
   V C R lmg ．
   BLM 30mg’
’2． 〈K） Maintenance Therapy
   CDDP 25mg


































25mg／m2を第1日目より5日間連続， BLM 10 ihg／m2
を第1日目より7日間連続，VCR 2 mg／m2を第1日
目に， 症例｝こよりPRD 20 mgを第1E！目より．7日
間連続投与．し，これを3～4週間毎に2～3クールお
こなう，
 main enance chemotherapyは1ヵ月毎におこなう












Case MetastasiscBv chemotherapy Effective survival KalnOfSkYlntensive Maintenanse Duration Evaluation
1 Lung








  Retroperitoneum 24  Colon course
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Fig． 1．CT FINDING of J．N．， 68 y．o．， in PRE






ール終了後10日目に最高BUN 71mgtdl creatininc 4・5
mg／d1に，症例4ではmaintenance chemotheraPy
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